推荐产品
化驗
≥98% (HPLC)
形狀
solid
溶解度
DMSO: 40 mg/mL
起源
AstraZeneca
儲存溫度
room temp
SMILES 字串
[n]2(ncnc2)Cc1cc(cc(c1)C(C)(C)C#N)C(C)(C)C#N
InChI
1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3
InChI 密鑰
YBBLVLTVTVSKRW-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
應用
阿那曲唑（芳香化酶抑制剂）已被用于：
- 在DNA片段分析中用作阳性对照
- 研究其与特级初榨橄榄油及其主要脂肪酸成分（omega-9 OA）对雌激素受体阳性乳腺癌细胞的作用
- 研究其对多形性胶质母细胞瘤体内模型存活率、细胞增殖和凋亡的影响
生化／生理作用
含有三唑官能团的阿那曲唑能够可逆地与芳香化酶的细胞色素P-450组分结合。这种结合会干扰芳香酶的催化特性，从而导致雌激素的合成受到抑制。
芳香化酶可将肾上腺雄激素转化为雌激素；这种酶活性是绝经后妇女雌激素的主要产生来源。 绝经后妇女雌激素受体阳性乳腺癌的一种治疗方法便是通过抑制芳香化酶。 阿那曲唑是一种非甾体苄基三唑衍生物，可通过竞争性抑制而对芳香化酶进行抑制，并用于治疗雌激素受体阳性的乳腺癌。 该化合物被认为是第三代II型芳香化酶抑制剂，因其与第一代、第二代抑制剂相比，针对其他甾体激素具有更强的选择性和更低的作用（如有）。
阿那曲唑是一种非甾体芳香酶抑制剂。
特點和優勢
该化合物由AstraZeneca开发。要浏览其他药物开发化合物和批准的药物/候选药物列表，单击此处。
訊號詞
Danger
危險聲明
危險分類
Acute Tox. 4 Oral - Repr. 1B
儲存類別代碼
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
其他客户在看
Novel acylated steroidal glycosides from Caralluma tuberculata induce caspase-dependent apoptosis in cancer cells
Waheed A, et al.
Journal of Ethnopharmacology, 137(3), 1189-1196 (2011)
Yanyan Hong et al.
Steroids, 76(8), 802-806 (2011-03-23)
Aromatase is the rate-limiting enzyme in estrogen biosynthesis. As a cytochrome P450, it utilizes electrons from NADPH-cytochrome P450 reductase (CPR) to produce estrogen from androgen. Estrogen is a key factor in the promotion of hormone-dependent breast cancer growth. Aromatase inhibitors
P Dubsky et al.
Annals of oncology : official journal of the European Society for Medical Oncology, 24(3), 640-647 (2012-10-05)
In early estrogen receptor (ER)-positive/HER2-negative breast cancer, the decision to administer chemotherapy is largely based on prognostic criteria. The combined molecular/clinical EndoPredict test (EPclin) has been validated to accurately assess prognosis in this population. In this study, the clinical relevance
F Boccardo et al.
European journal of cancer (Oxford, England : 1990), 49(7), 1546-1554 (2013-02-19)
The Italian Tamoxifen Anastrozole (ITA) trial investigated the efficacy of switching to anastrozole for women who were already on adjuvant tamoxifen since 2-3years. Relapse-free survival (RFS) was the primary end-point; event-free survival (EFS), overall survival (OS) and safety were secondary
P I Petkov et al.
SAR and QSAR in environmental research, 20(7-8), 657-678 (2009-12-22)
Cytochrome P450 aromatase is a key steroidogenic enzyme that converts androgens to estrogens in vertebrates. There is much interest in aromatase inhibitors (AIs) both because of their use as pharmaceuticals in the treatment of estrogen-sensitive breast cancers, and because a
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门